Top compounds associated with response to TRAPPC9


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel gCSI pan-cancer AAC -0.35 3e-11
mRNA Docetaxel gCSI pan-cancer AAC -0.32 9e-10
mRNA Doxorubicin gCSI pan-cancer AAC -0.28 7e-08
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 7e-07
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 5e-06
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA Imatinib GDSC1000 pan-cancer AAC 0.22 5e-05
mRNA thapsigargin gCSI pan-cancer AAC -0.23 5e-05
mRNA lovastatin CTRPv2 pan-cancer AAC -0.15 7e-05
mRNA Nilotinib CCLE pan-cancer AAC 0.21 8e-05
Download CSV